← Назад к работе
Работы, на которые ссылается эта работа
Работ: 16
Работа: A 24-Week, All-Oral Regimen for Rifampin-Resistant Tuberculosis
Treatment of Highly Drug-Resistant Pulmonary Tuberculosis
Francesca Conradie, Andreas H. Diacon, Nosipho Ngubane +15
Статья2020Цитирований: 7ABIA Trial of a Shorter Regimen for Rifampin-Resistant Tuberculosis
Andrew Nunn, Patrick Phillips, Sarah Meredith +16
Статья2019Цитирований: 6ABIBedaquiline–Pretomanid–Linezolid Regimens for Drug-Resistant Tuberculosis
Francesca Conradie, Tatevik R. Bagdasaryan, Borisov Se +25
Статья2022Цитирований: 6ABIPrinciples for designing future regimens for multidrug-resistant tuberculosis
Grania Brigden, Bern-Thomas Nyang’wa, Philipp du Cros +9
Статья2013Цитирований: 3ABIDrug-associated adverse events in the treatment of multidrug-resistant tuberculosis: an individual patient data meta-analysis
Zhiyi Lan, Nafees Ahmad, Parvaneh Baghaei +35
Обзорная статья2020Цитирований: 3ABIFinancial burden for tuberculosis patients in low- and middle-income countries: a systematic review
Tadayuki Tanimura, Ernesto Jaramillo, Diana Weil +2
Обзорная статья2014Цитирований: 2ABISafety and Effectiveness of an All-Oral, Bedaquiline-Based, Shorter Treatment Regimen for Rifampicin-Resistant Tuberculosis in High Human Immunodeficiency Virus (HIV) Burden Rural South Africa: A Retrospective Cohort Analysis
Ilse Tack, Asnake Yohannes Dumicho, Liesbet Ohler +6
Статья2020Цитирований: 2ABI